CBD Boosts Sexual Motivation in Male Rats, Study Finds

Could CBD influence sexual desire without producing the intoxicating effects associated with THC? A new animal study offers a reason to investigate that possibility, while showing why the answer is unlikely to come down to simply taking more cannabidiol.

Researchers found that oral CBD increased certain measures of sexual motivation in male rats and, at a particular dose, reversed the temporary sexual inhibition that follows mating to satiety. Two weeks of daily treatment also produced no detected impairment in the sexual behaviours measured in sexually active males.

The findings do not establish CBD as a treatment for low libido in people. They do, however, suggest a more useful research direction than the broad question of whether cannabis improves sex: identifying which component of sexual function might respond, under what conditions, and within what dose range.

What the CBD Sexual Motivation Study Found

The study accepted for publication in Neuroscience¹, by Gabriela Rodríguez-Manzo, Ana Canseco-Alba, and Jorge Rojas-Hernández, examined sexually experienced male rats in two conditions. Some were sexually active, while others had mated to satiety and entered a period of reduced sexual responsiveness.

This distinction matters. Testing only sexually active animals could reveal whether CBD disrupts normal behaviour, but might miss effects that become apparent when motivation is suppressed. Each experimental group contained eight males.

Researchers administered CBD dissolved in medium-chain triglyceride oil directly into the stomach, 60 minutes before testing. Control animals received the carrier oil. The team recorded behaviours including mounting, penetration, ejaculation, and the time taken to initiate sexual activity.

In sexually active males, 15 mg/kg CBD shortened the time before mounting and penetration. At 90 mg/kg, those waiting times increased instead. The direction of the response therefore changed with dose.

The clearest result appeared in sexually satiated rats given 30 mg/kg. All eight mounted, achieved penetration, and ejaculated, while seven resumed mating after ejaculation. These responses were significantly more frequent than in the corresponding control group.

Sexual Motivation Is Different From Sexual Performance

One valuable feature of this research is its attempt to separate motivation from the mechanics of mating. Starting sexual activity sooner can suggest greater motivation, but that observation alone cannot explain why an animal approaches a partner.

The researchers therefore used a separate sexual incentive motivation test. Male rats could investigate areas near a sexually receptive female or another male, with physical barriers preventing mating. This allowed the team to assess attraction without relying entirely on copulatory behaviour.

CBD increased preference for the female in sexually satiated males at the effective 30 mg/kg dose. Locomotor testing found no significant changes in spontaneous movement at the doses tested, making a general increase in physical activity a less convincing explanation.

These results support a motivational interpretation, although they do not directly measure human desire. A rat approaching a receptive female cannot capture a person’s experience of attraction, pleasure, distress, or relationship satisfaction.

That distinction could improve future clinical research. Desire, erection, orgasm, pain, and satisfaction are connected, but they are different outcomes. A treatment that affects one should not automatically be described as improving them all.

Why More CBD May Not Produce Better Results

The study’s dose-response pattern is particularly relevant to a market where higher milligram counts can appear synonymous with greater effectiveness.

Among sexually satiated animals, the strongest overall response occurred at 30 mg/kg. The lower dose did not significantly reverse inhibition, while 60 mg/kg significantly increased mounting without producing the same broader recovery. In sexually active animals, the highest tested dose delayed initiation.

This suggests that the animal’s starting condition and the amount administered both influenced the outcome. It also means that no single dose emerged as universally beneficial across the experiments.

Absorption Could Become Part of the Treatment Question

These rat doses are not instructions for human consumption. Species differences, metabolism, formulation, and exposure prevent a straightforward conversion into a recommended serving of retail CBD oil.

MyCannabis recently examined CBD absorption and emerging delivery technologies. That work highlights a related challenge: the amount swallowed and the amount reaching circulation are different measurements.

If CBD eventually proves useful for a particular sexual condition, consistent exposure may matter as much as the number printed on a bottle. Formulation research would then serve a clinical purpose: helping researchers reproduce an effective response rather than merely increasing absorption.

What Might Explain CBD’s Effects on Desire?

The authors discuss several possible biological pathways, but their experiments did not establish which mechanism caused the behavioural changes.

One possibility involves anandamide, a signalling molecule produced by the body’s endocannabinoid system. The researchers propose that CBD could influence its availability through effects involving fatty acid amide hydrolase, an enzyme that breaks anandamide down.

Previous animal research from the group found dose-dependent effects of anandamide on sexual behaviour resembling parts of the CBD response. That similarity provides a hypothesis worth testing, rather than proof of a shared mechanism.

CBD also interacts with multiple other signalling systems. Future experiments could selectively block candidate pathways to determine which are necessary for the observed effects. Understanding that mechanism could help explain why responses differed between sexually active and sexually inhibited animals.

How This Fits Into Human Sexual Health Research

Cannabinoid research already extends beyond male sexual motivation. MyCannabis has covered cannabis research involving female orgasmic difficulty, another area where separating specific symptoms from general sexual satisfaction is essential.

A 2025 randomized trial of topical CBD plus myrcene investigated vestibulodynia, a condition involving pain around the vaginal entrance. That research addressed a different problem, used a different delivery route, and combined CBD with another compound. It cannot validate oral CBD for low desire, but illustrates why cannabinoid sexual health research needs condition-specific questions.

Fertility requires its own evidence, too. A 2025 laboratory study of cannabinoids and human sperm found that THC and CBD affected calcium signalling involving CatSper channels. The authors emphasized that further studies were needed to determine implications for fertility.

Neither laboratory sperm findings nor rat mating behaviour can establish real-world reproductive outcomes. Together, they reinforce the need to measure motivation, sexual function, and fertility separately.

What Future CBD Trials Need to Establish

The next useful step would be carefully designed human research involving people with a clearly defined concern, rather than a general population asked whether CBD makes sex better.

Important questions include:

• Does a standardized CBD formulation improve desire compared with placebo?
• Do any benefits depend on dose, timing, or the underlying cause of low desire?
• Are improvements meaningful to participants, and what adverse effects occur?

The two-week rat treatment provides a limited reassurance signal: researchers did not detect impaired sexual behaviour in the sexually active males studied. It does not establish long-term safety, effects in females, fertility outcomes, or safety in animals with pre-existing dysfunction.

For readers comparing existing products, MyCannabis’s CBD oils and tinctures buying guide explains concentration, cannabinoid profiles, and batch documentation. Those distinctions help identify what a product contains, but cannot establish that it treats low libido or reproduces the experimental preparation.

A More Precise Direction for CBD Research

The encouraging development here is a testable research lead. CBD affected sexual motivation in a controlled animal model, and the response depended on both dose and initial sexual state.

That gives researchers a more focused starting point for exploring whether a similar effect exists in people. Progress would mean identifying who might benefit, measuring outcomes that matter to them, and establishing a reproducible formulation. This study moves that investigation forward without settling its clinical answer.

References:

¹ Rodríguez-Manzo, G., Canseco-Alba, A., & Rojas-Hernández, J. (2026). Cannabidiol’s prosexual effects in sexually active and sexually inhibited male rats. Neuroscience. Advance online publication. https://doi.org/10.1016/j.neuroscience.2026.10.029